Status:
NOT_YET_RECRUITING
A Biological Signature for the Early Differential Diagnosis of Psychosis
Lead Sponsor:
IRCCS San Raffaele
Collaborating Sponsors:
Ministry of Health, Italy
Conditions:
Schizophrenia
Bipolar Disorder
Eligibility:
All Genders
18-65 years
Brief Summary
Schizophrenia (SZ) and mood disorders (BD, MDD) are among the most disabling disorders worldwide, with a relevant social, functional, and economic burden. Although they are identified as distinct diso...
Eligibility Criteria
Inclusion
- Aged 18-65
- diagnosed with Schizophrenia, Bipolar Disorder or Major depressive disorder.
- For Bipolar and Major depressive disorder, Hamilton Depression Rating Scale scores \>8
- Multimodal 3 T MRI acquisition available (\*)
- Genetic and serum inflammatory data available, or serum and whole blood available for genotyping and inflammatory markers determination.
Exclusion
- Presence of major medical or neurological disorders
- Alcohol or drugs abuse or dependence
- Conditions known to alter immune-inflammatory status, such as rheumatic diseases, malignancies,
- ongoing treatment with drugs acting on the immune system, such as corticosteroids, NSAIDs and other immunomodulatory drugs.
- Pregnancy or lactating
Key Trial Info
Start Date :
August 31 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
1850 Patients enrolled
Trial Details
Trial ID
NCT06515522
Start Date
August 31 2024
End Date
August 1 2026
Last Update
July 23 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.